Life Sciences

Accelerate research with a direct connection to patients

Access Evidation’s highly engaged health community to effectively recruit for your trials, engage patients over time, and go to market faster.

Circular design in yellow and purple gradient

Trial Recruitment and Experience

Understand patients’ experiences and unmet needs to reduce burden and increase retention through an ongoing connection to patients

Quickly test hypotheses with digital measures and fast responses from an engaged health community

Accelerate enrollment into your trials by recruiting from a well-characterized, engaged, and research-motivated community

Meet your diversity goals with access to 97% of U.S. zip codes and social determinants of health data

Elderly woman with gray hair wearing a pink shirt.

Generating Real-World Evidence

Quantify health and quality of life outcomes with longitudinal data collected directly from patients, including validated ePROs and objective digital measures

Demonstrate value at every stage of treatment development through a deeper understanding of the patient experience, unmet needs, and underserved groups

Differentiate treatment value and support stakeholder decisions with evidence aligned to emerging drivers of market value

Publish peer-reviewed communications to increase treatment consideration and shape clinical guidelines with data collected through prospective, longitudinal real-world studies

Two elderly women enjoying a swim in the pool.

Commercial Planning

Build more robust patient journeys with longitudinal surveys, validated ePROs, and digital measures

Increase access by uncovering patient journey barriers and opportunities to intervene outside of traditional care settings

Respond to questions faster with access to our responsive, well-characterized community

Boost marketing effectiveness with more nuanced segmentation based on real-world measures

Prioritize investment decisions with a deeper understanding of what’s actually driving patient behavior and outcomes in everyday life

A woman sitting on a couch, looking at her phone.

WORK WITH US

Solutions we offer for life sciences companies:

Trial Recruitment

Patient Insights
‍

Patient Experience Datasets

Real-World
Studies

Research & Engagement Platform

Segmenting patients by real-world symptom control

Evidation partnered with a leading pharmaceutical company to understand the asthma patient journey and management experience.

14K

individuals with asthma recruited from the Evidation Community

Recruitment completed in

1 week

READ

Identifying and addressing gaps in the patient experience

Myovant uncovered significant unmet needs among individuals with uterine fibroids (UF) in a direct-to-patient 4-month study with 350 women living with UF.

92%

weekly survey completion

85%

daily survey completion

READ

Low-burden, objective assessment of symptoms and disease progression

Evidation partnered with a large pharmaceutical company to conduct a real-world study to create a more complete picture of multiple sclerosis (MS) patients’ experiences by combining data from wearable devices with medical claims and demographics data.

500+

individuals with MS recruited from the Evidation Community

Patients who switched therapies had neuro MRIs

1.5x

more often than those on a single therapy

READ

Increasing treatment rates with co-created patient engagement

Evidation partnered with Sanofi to test and refine content and messaging for a Type 2 diabetes flu vaccine education program.

10K

indviduals recruited from the Evidation Community

Up to

increase in vaccination rates for participants who engaged with customized diabetes campaign vs. those who engaged with generic messaging

READ

Members who suffer from migraines receive personal health feedback

Evidation developed, and deployed, MigraineSmart, a symptom tracking health program that collects direct-from-participant data and provides educational content and personalized insights to participants, helping them better understand and manage their migraines.

3K+

individuals participated in the MigraineSmart program

48%

said that tracking helps them better understand symptom patterns and migraine triggers

READ

Exploring potential to reduce stroke risk with earlier detection of Afib

Evidation partnered with Johnson&Johnson to support a multi-year, observational study that sought to assess whether the Heartline^™ Study app on iPhone, and the ECG app and irregular rhythm notification feature on Apple Watch, can reduce the likelihood of stroke and improve health outcomes with earlier detection of atrial fibrillation.

30K+

participants aged 65+

READ

Rapid enrollment of representative population in COVID-19 research

Evidation partnered with a leading pharmaceutical company to build a patient engagement program focused on COVID-19 that engages a representative population across the United States.

100K

individuals enrolled into reseach program in 5 weeks

90%+

program engagement

1.5K

of those participants recruited into real-world evidence study in 2 weeks

READ

Measuring cognitive impairment with direct-from-patient real-world data

Evidation partnered with Eli Lilly to develop new endpoints and identify digital signals of cognitive impairment through the use of digital and wearable devices, mobile apps, and sleep sensors.

16TB

of multimodal data collected over 12 weeks

1K+

features extracted from participant behaviorgrams

READ

Developing more successful digital health programs with patient perspectives

Evidation partnered with Sanofi to get data-driven insights to prioritize program features and future development of a connected ecosystem for managing type 2 diabetes (T2D).

114

insulin-dependent adults with T2D recruited from the Evidation community

Recruitment completed in

3 weeks

READ

Demonstrating improved quality of life and activity levels in PNH patients

Evidation partnered with a leading pharmaceutical company to conduct a 32-week direct-to-participant study with paroxysmal nocturnal hemoglobinuria (PNH) patients to characterizes patient experiences while using a C5 inhibitor.

30+

indviduals diagnosed with PNH and taking a specific therapy

>80%

compliance with study activities

READ

< Previous | Next >

Therapeutic experience